Counselors in Kansas City, KS Accepting Medicare
112 Counselors found. Showing 81 - 100
 Ms. Meredith Mclaughlin Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1125 N 5th St, Kansas City, KS 66101 Phone: 913-342-0888 |
Elizabeth Jurado Counselor Medicare: Not Enrolled in Medicare Practice Location: 1265 Sumner Ave, Kansas City, KS 66102 Phone: 913-281-3568 |
Jasmin Roland, LPC, PLPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2708 W 43rd Ave, Kansas City, KS 66103 Phone: 913-708-8247 |
Rachel Elizabeth Marcy Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1814 S 32nd St, Kansas City, KS 66106 Phone: 785-248-3222 |
Talia Wolken, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-563-6500 |
Chastity Jo Nichols, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-328-4821 |
Ms. Katherine Marie St.john, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 711 Armstrong Ave, Kansas City, KS 66101 Phone: 913-233-3337 |
Ms. Kimberly Lynn Spearman, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 757 Armstrong Ave, Kansas City, KS 66101 Phone: 913-233-3300 |
Silvia Noelia Schnopp, LMLP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-328-4600 |
Debra Terrell Mckenzie, LCAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1121 N 5th St, Kansas City, KS 66101 Phone: 800-423-1342 Fax: 785-628-3113 |
 Steven E Murdock Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 21 N 12th St Ste 400, Kansas City, KS 66102 Phone: 816-923-5800 |
Jill Dollins Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 6723 State Ave, Kansas City, KS 66102 Phone: 913-871-7600 |
Godswill Okorafor Chuku, LMAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1121 N 5th St, Kansas City, KS 66101 Phone: 913-831-2820 |
Ms. Tracie Lynn Camlin, LCAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 630 Minnesota Ave Ste 204, Kansas City, KS 66101 Phone: 913-281-1995 Fax: 913-281-2317 |
Katherine Raue Counselor Medicare: Not Enrolled in Medicare Practice Location: 2708 W 43rd Ave, Kansas City, KS 66103 Phone: 816-708-8247 |
Rachael Gallas, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd., Mailstop 4015, Kansas City, KS 66160 Phone: 913-945-7031 |
Jessica Smith, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1024 Hoel Pkwy, Kansas City, KS 66102 Phone: 913-371-9668 Fax: 913-371-9688 |
Carol R Washington, MS/LCAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 21 N 12th St, Suite 470, Kansas City, KS 66102 Phone: 913-371-0352 |
Astra J Haney, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-328-4600 Fax: 913-328-4683 |
Dr. Erin Linne Gaal, EDD Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 4311 N 110th Ter, Kansas City, KS 66109 Phone: 352-638-4964 |
News Archive
The International Consortium Claims Medical Breakthrough in Malaria Research
An international consortium led by researchers in Sweden and Switzerland has conducted a genome-wide study that the team is calling a "medical breakthrough" in malaria research.
FDA issues Complete Response Letter for approval of Eisai's rabeprazole sodium extended-release capsules
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
New schizophrenia treatment
Schizophrenia is one of the most debilitating of the major psychiatric disorders, and is also one of the most difficult to treat.
Black women with wide waists are equally at risk of early death as whites
Ever since the mid-1970s when Harvard initiated what is now known as "The Nurses Study" we've been told that white women with waists over 40 inches, raised their risk of early death by 40% vs. their slimmer sisters who maintained waists in the 26 to 27 inch measure.
› Verified 3 days ago
Counselors
Pharmacists
Dentists
Psychologists
Clinical Social Workers
Occupational Therapists